MemRAY BT stock price
KRX:072770 · KOSDAQ · Software · sector #18MemRAY BT's chart data is dated 2026-11-06. There is no active technical signal. The display ticker is 072770.
- MemRAY BT's 52-week range runs from ₩1,438 to ₩6,950. The latest close of ₩1,600 is near the bottom of that range (−77.0% from the high).
- By close, the price moved +4.6% over 1 month, −13.8% over 3 months, −54.7% over 6 months, −74.2% over 1 year.
- No technical signal is active today.
MemRAY BT Talk · Newest
For account, order or payment questions, please send a 1:1 inquiry · 1:1 inquiry →
Loading Talk…
MemRAY BT last closed at ₩1,600 (-5.94%) on 2026-11-06. Listed on KOSDAQ. Trailing 12 months PER is -3.6×. Its overall grade ranks 159 of 199 stocks in Software.
MemRAY BT overview
MemRAY BT is listed on KOSDAQ and classified in the Software sector. Its market capitalization is about KRW 70.61B. PER -3.6× and PBR 1.54× on the latest published figures. Trading records run from 2025-10-30 to 2026-11-06, a full year or more.
Revenue held roughly steady from KRW 90B in 2023 to KRW 89.63B in 2025 (−0%).
Position within its sector
Among 199 stocks in Software, MemRAY BT ranks No. 159 on the overall grade (C), within the top 80% of its sector.
By factor, valuation (A, top 18%) and growth (B+, top 40%) stand out the most, while financial quality (F, top 94%) is the weakest of the 5.
Grades are relative positions within the same sector, shown for reference only.
About this company
Quantus's relationship data lists competitors: Samsung Biologics, Celltrion, La-Z-Boy and 3 more; customers: Amgen, Rogers, Pfizer and 4 more.
By revenue it ranks No. 59 of the 188 companies with revenue data in Software, with 0.2% of the sector's total revenue.
The sector is fragmented: its top three companies hold 40.0% of revenue.
Reported results
Position in sector
Software · Overall C · 159/199
Valuation grade A
Recent filings
DART · received recent list, not a complete filing history. Factual information, not investment advice.
Related stocks
- Samsung BiologicsCompetitor
- CelltrionCompetitor
- 롯데바이오로직스Competitor
About MemRAY BT
- What published figures are available for MemRAY BT?
- Market cap: KRW 70.61B. Trailing 12 months PER: -3.6×. Latest quarter PBR: 1.54×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-11-06 dataset
Turn what you saw on this name into a strategy
Ask Q about MemRAY BT, or open the plan table on the main site.
Ask Q about MemRAY BT.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.